Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study
Fig 5
Subset analyses of the relationship between OS and inflammatory markers, according to clinical factors.
Data are presented as forest plots, with hazard ratios (HR), associated confidence intervals (CI) and p-values for each group. Data for each inflammatory marker appears in a separate panel, as follows (with cut-off level); (A) Alb (g/dL); ≥ 3.5/< 3.5, (B) CRP (mg/dL); ≥ 0.3/< 0.3, (C) LDH (U/L); ≥ 222/< 222, (D) NLR; ≥ 2.56/< 2.56, (E) LMR; ≥ 5.11/< 5.11, (F) PLR; ≥ 164/< 164, (G) dNLR; ≥ 1.92/< 1.92, and (H) LMR/LDH (%); ≥ 2.91/< 2.91. Alb, albumin; CRP, C-reactive protein; dNLR, derived neutrophil-lymphocyte ratio; LDH, lactate dehydrogenase; LMR, lymphocyte-monocyte ratio; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio.